Morgan Stanley’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$124K Sell
131,393
-510,236
-80% -$483K ﹤0.01% 6051
2025
Q1
$296K Buy
641,629
+115,479
+22% +$53.2K ﹤0.01% 5568
2024
Q4
$389K Buy
526,150
+71,173
+16% +$52.6K ﹤0.01% 5527
2024
Q3
$714K Buy
454,977
+100,941
+29% +$158K ﹤0.01% 5232
2024
Q2
$595K Buy
354,036
+109,827
+45% +$185K ﹤0.01% 5210
2024
Q1
$586K Sell
244,209
-1,591,167
-87% -$3.82M ﹤0.01% 5237
2023
Q4
$2.81M Buy
1,835,376
+1,595,756
+666% +$2.44M ﹤0.01% 4746
2023
Q3
$261K Sell
239,620
-34,923
-13% -$38.1K ﹤0.01% 5461
2023
Q2
$629K Buy
274,543
+76,239
+38% +$175K ﹤0.01% 5103
2023
Q1
$482K Buy
198,304
+62,462
+46% +$152K ﹤0.01% 5279
2022
Q4
$259K Sell
135,842
-33,241
-20% -$63.5K ﹤0.01% 5560
2022
Q3
$405K Sell
169,083
-399,825
-70% -$958K ﹤0.01% 5371
2022
Q2
$1.06M Buy
568,908
+382,326
+205% +$710K ﹤0.01% 4984
2022
Q1
$390K Buy
186,582
+78,114
+72% +$163K ﹤0.01% 5554
2021
Q4
$427K Buy
108,468
+8,893
+9% +$35K ﹤0.01% 5639
2021
Q3
$479K Sell
99,575
-35,186
-26% -$169K ﹤0.01% 5523
2021
Q2
$619K Sell
134,761
-570,377
-81% -$2.62M ﹤0.01% 5387
2021
Q1
$4.14M Sell
705,138
-1,374,999
-66% -$8.07M ﹤0.01% 3604
2020
Q4
$7.11M Buy
2,080,137
+691,695
+50% +$2.37M ﹤0.01% 2874
2020
Q3
$2M Sell
1,388,442
-627,739
-31% -$904K ﹤0.01% 3659
2020
Q2
$4.02M Buy
2,016,181
+1,856,279
+1,161% +$3.7M ﹤0.01% 2897
2020
Q1
$312K Sell
159,902
-282,344
-64% -$551K ﹤0.01% 4642
2019
Q4
$1.84M Sell
442,246
-32,606
-7% -$135K ﹤0.01% 4112
2019
Q3
$1.43M Buy
474,852
+279,545
+143% +$841K ﹤0.01% 4065
2019
Q2
$1.23M Buy
195,307
+119,611
+158% +$753K ﹤0.01% 4112
2019
Q1
$421K Sell
75,696
-65,091
-46% -$362K ﹤0.01% 4653
2018
Q4
$935K Buy
140,787
+51,822
+58% +$344K ﹤0.01% 4323
2018
Q3
$950K Sell
88,965
-58,240
-40% -$622K ﹤0.01% 4576
2018
Q2
$1.77M Buy
147,205
+40,700
+38% +$489K ﹤0.01% 4194
2018
Q1
$912K Sell
106,505
-5,494
-5% -$47K ﹤0.01% 4606
2017
Q4
$1.11M Buy
111,999
+7,628
+7% +$75.4K ﹤0.01% 4468
2017
Q3
$1.28M Buy
104,371
+32,557
+45% +$400K ﹤0.01% 4259
2017
Q2
$1.18M Sell
71,814
-102,951
-59% -$1.69M ﹤0.01% 4250
2017
Q1
$2.51M Buy
174,765
+32,276
+23% +$463K ﹤0.01% 3612
2016
Q4
$1.97M Buy
142,489
+21,709
+18% +$300K ﹤0.01% 3943
2016
Q3
$2.18M Buy
120,780
+97,904
+428% +$1.77M ﹤0.01% 3436
2016
Q2
$328K Sell
22,876
-25,025
-52% -$359K ﹤0.01% 4671
2016
Q1
$573K Buy
47,901
+44,436
+1,282% +$532K ﹤0.01% 4344
2015
Q4
$47K Sell
3,465
-13,492
-80% -$183K ﹤0.01% 5739
2015
Q3
$182K Sell
16,957
-20,523
-55% -$220K ﹤0.01% 5127
2015
Q2
$302K Buy
37,480
+4,581
+14% +$36.9K ﹤0.01% 5024
2015
Q1
$218K Sell
32,899
-104,772
-76% -$694K ﹤0.01% 5162
2014
Q4
$876K Buy
137,671
+116,421
+548% +$741K ﹤0.01% 4252
2014
Q3
$210K Sell
21,250
-20,754
-49% -$205K ﹤0.01% 5119
2014
Q2
$473K Buy
42,004
+20,408
+94% +$230K ﹤0.01% 4614
2014
Q1
$262K Sell
21,596
-11,247
-34% -$136K ﹤0.01% 4963
2013
Q4
$414K Sell
32,843
-13,748
-30% -$173K ﹤0.01% 4585
2013
Q3
$776K Sell
46,591
-171,744
-79% -$2.86M ﹤0.01% 4008
2013
Q2
$3.32M Buy
+218,335
New +$3.32M ﹤0.01% 2714